Suppr超能文献

一项遗传筛选的适应性研究揭示了一种线粒体蛋白输入组件Tim44的抑制剂。

Adaptation of a Genetic Screen Reveals an Inhibitor for Mitochondrial Protein Import Component Tim44.

作者信息

Miyata Non, Tang Zhiye, Conti Michael A, Johnson Meghan E, Douglas Colin J, Hasson Samuel A, Damoiseaux Robert, Chang Chia-En A, Koehler Carla M

机构信息

From the Departments of Chemistry and Biochemistry and.

the Department of Chemistry, University of California Riverside, Riverside, California 92521.

出版信息

J Biol Chem. 2017 Mar 31;292(13):5429-5442. doi: 10.1074/jbc.M116.770131. Epub 2017 Feb 6.

Abstract

Diverse protein import pathways into mitochondria use translocons on the outer membrane (TOM) and inner membrane (TIM). We adapted a genetic screen, based on Ura3 mistargeting from mitochondria to the cytosol, to identify small molecules that attenuated protein import. Small molecule mitochondrial import blockers of the Carla Koehler laboratory (MB)-10 inhibited import of substrates that require the TIM23 translocon. Mutational analysis coupled with molecular docking and molecular dynamics modeling revealed that MB-10 binds to a specific pocket in the C-terminal domain of Tim44 of the protein-associated motor (PAM) complex. This region was proposed to anchor Tim44 to the membrane, but biochemical studies with MB-10 show that this region is required for binding to the translocating precursor and binding to mtHsp70 in low ATP conditions. This study also supports a direct role for the PAM complex in the import of substrates that are laterally sorted to the inner membrane, as well as the mitochondrial matrix. Thus, MB-10 is the first small molecule modulator to attenuate PAM complex activity, likely through binding to the C-terminal region of Tim44.

摘要

多种蛋白质进入线粒体的途径利用线粒体外膜转位酶(TOM)和内膜转位酶(TIM)。我们基于尿嘧啶核苷酸磷酸核糖转移酶(Ura3)从线粒体错误定位到细胞质,采用了一种遗传筛选方法,以鉴定能减弱蛋白质导入的小分子。卡拉·克勒实验室的小分子线粒体导入阻滞剂(MB)-10抑制了需要TIM23转位酶的底物的导入。突变分析结合分子对接和分子动力学建模表明,MB-10与蛋白质相关马达(PAM)复合体的Tim44 C末端结构域中的一个特定口袋结合。该区域被认为可将Tim44锚定在膜上,但用MB-10进行的生化研究表明,该区域在低ATP条件下对于与转运前体结合以及与线粒体热休克蛋白70(mtHsp70)结合是必需的。这项研究还支持PAM复合体在将底物侧向分选到内膜以及线粒体基质的导入过程中发挥直接作用。因此,MB-10是首个可能通过结合Tim44的C末端区域来减弱PAM复合体活性的小分子调节剂。

相似文献

7

引用本文的文献

8
TIMM44 is a potential therapeutic target of human glioma.TIMM44 是人类脑胶质瘤的一个潜在治疗靶点。
Theranostics. 2022 Oct 31;12(17):7586-7602. doi: 10.7150/thno.78616. eCollection 2022.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验